Undervalued Asian Small Caps With Insider Action For September 2026

As the Asian markets navigate through a landscape marked by fluctuating oil prices and evolving geopolitical tensions, small-cap stocks in the region are drawing attention for their potential resilience and growth opportunities. In this environment, identifying small-cap stocks with strong fundamentals and insider activity could present unique investment insights, especially as market dynamics continue to shift.

Top 10 Undervalued Small Caps With Insider Buying In Asia

Name	PE	PS	Discount to Fair Value	Value Rating
Autosports Group	11.6x	0.1x	45.98%	★★★★★★
Credit Corp Group	9.2x	2.0x	41.47%	★★★★★☆
DMCI Holdings	6.1x	0.9x	42.39%	★★★★☆☆
Australian Finance Group	8.5x	0.3x	13.78%	★★★★☆☆
Domino's Pizza Enterprises	NA	1.0x	15.10%	★★★★☆☆
Storage King Group	9.4x	5.9x	6.68%	★★★★☆☆
Aztech Global	13.0x	1.1x	-107.05%	★★★☆☆☆
China Yongda Automobiles Services Holdings	NA	0.0x	-69.15%	★★★☆☆☆
Hong Fok	23.4x	6.8x	29.82%	★★★☆☆☆
Paragon Care	NA	0.1x	-12.00%	★★★☆☆☆

Click here to see the full list of 46 stocks from our Undervalued Asian Small Caps With Insider Buying screener.

Here we highlight a subset of our preferred stocks from the screener.

Growthpoint Properties Australia (ASX:GOZ)

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Growthpoint Properties Australia focuses on owning and managing a diversified portfolio of office and industrial properties, with a market capitalization of A$3.36 billion.

Operations: Growthpoint Properties Australia's primary revenue streams are derived from its Office and Industrial segments, generating A$218.60 million and A$95.70 million respectively. Over recent periods, the net income margin has shown significant fluctuations, with a notable decline to -0.81% in late 2023 before recovering to 0.27% by mid-2026.

PE: 17.0x

Growthpoint Properties Australia, a smaller player in the Asian market, recently reported a turnaround with net income of A$90.8 million for the year ending June 2026, compared to a net loss previously. The company maintains its dividend guidance at 18.4 cents per share for fiscal year 2027, reflecting stability despite higher risk funding from external borrowing. Insider confidence is evident with recent leadership changes; Nathan Thomas joined as Chief Investment Officer in July 2026 to enhance investment strategies and growth prospects.

• Get an in-depth perspective on Growthpoint Properties Australia's performance by reading our valuation report here.

• Explore historical data to track Growthpoint Properties Australia's performance over time in our Past section.

Robinsons Land (PSE:RLC)

Simply Wall St Value Rating: ★★★★☆☆

Overview: Robinsons Land is a diversified real estate company engaged in the development and operation of shopping malls, offices, hotels and resorts, logistics and industrial facilities, and residential properties with a market capitalization of approximately ₱100 billion.

Operations: The company's revenue streams are primarily driven by its malls, offices, hotels and resorts, logistics and industrial facilities, and residential division. The gross profit margin has shown fluctuations over the periods observed but reached 55.30% in September 2024. Significant operating expenses include general and administrative costs alongside sales and marketing expenses. Net income margin has also varied across the periods but was recorded at 28.41% in September 2025.

PE: 6.1x

Robinsons Land, a dynamic player in Asia's investment landscape, shows signs of being undervalued with its recent financial performance. For the second quarter ending June 2026, sales increased to PHP 5.78 billion from PHP 5.44 billion the previous year, while net income rose to PHP 3.67 billion from PHP 3.40 billion. Despite relying solely on external borrowing for funding, insider confidence is evident with share purchases over recent months, suggesting optimism about future growth prospects as earnings are projected to grow annually by 8.64%.

• Click here to discover the nuances of Robinsons Land with our detailed analytical valuation report.

• Gain insights into Robinsons Land's past trends and performance with our Past report.

Edding Genor Group Holdings (SEHK:6998)

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Edding Genor Group Holdings is a biopharmaceutical company focused on the research, development, and commercialization of oncology drugs, with a market capitalization of approximately CN¥1.5 billion.

Operations: Edding Genor Group Holdings generates revenue primarily through its core business operations, with recent figures showing CN¥2.55 billion in revenue as of December 2024. The gross profit margin has shown a slight upward trend, reaching 68.15% by the end of 2025. Operating expenses are significant, with sales and marketing being the largest component, followed by general and administrative expenses and R&D costs. Net income margins have varied over recent periods, reflecting changes in non-operating expenses and overall cost management strategies.

PE: 13.1x

Edding Genor Group Holdings, a small-cap player in Asia, has faced challenges with declining sales and a shift from net profit to net loss for the half year ending June 2026. Sales fell to CNY 872.73 million from CNY 1,135.54 million the previous year, while innovative drugs like Vascepa showed promising growth. Insider confidence is evident as insiders have been purchasing shares throughout the past few months. The company’s focus on innovation and strategic R&D investments aims to solidify its market position in high-growth therapeutic areas such as breast cancer treatment and chronic diseases, potentially paving the way for long-term shareholder value creation.

• Click to explore a detailed breakdown of our findings in Edding Genor Group Holdings' valuation report.

• Evaluate Edding Genor Group Holdings' historical performance by accessing our past performance report.

Where To Now?

• Discover the full array of 46 Undervalued Asian Small Caps With Insider Buying right here.
• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
• Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com